Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shufen Cao

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancers|January 21, 2022
Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell CarcinomaW Quinn O'Neill, Xiujie Xie, Shanying Gui, et al.
Cancer Medicine|April 27, 2023
Survival in elderly patients with breast cancer with and without autoimmune diseaseDemitrios Dedousis, Annie L Zhang, Anastasia N Vassiliou, et al.
Cancer Management and Research|September 7, 2023
Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic StatusMatthew M Mirsky, Carley Mitchell, Augustine Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Bone Marrow Transplantation|September 18, 2020
History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
Leukemia & Lymphoma|January 19, 2021
Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemiaJiasheng Wang, Marcos de Lima, Brenda W Cooper, et al.
American Journal of Hematology|April 21, 2020
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction modelsGouri Dharmavaram, Shufen Cao, Suchitra Sundaram, et al.
Structure (London, England : 1993)|December 25, 2018
A Metastable Contact and Structural Disorder in the Estrogen Receptor Transactivation DomainYi Peng, Shufen Cao, Janna Kiselar, et al.
Leukemia & Lymphoma|July 12, 2020
Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemiaNaveed Ali, Benjamin Tomlinson, Leland Metheny, et al.
Transplantation and Cellular Therapy|April 8, 2021
Physical Activity and Sleep Measures Using a Fitness Tracking Device during Hematopoietic Cell Transplantation: A Pilot StudyNajla El Jurdi, Nora Nock, Pingfu Fu, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancers|January 21, 2022
Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell CarcinomaW Quinn O'Neill, Xiujie Xie, Shanying Gui, et al.
Cancer Medicine|April 27, 2023
Survival in elderly patients with breast cancer with and without autoimmune diseaseDemitrios Dedousis, Annie L Zhang, Anastasia N Vassiliou, et al.
Cancer Management and Research|September 7, 2023
Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic StatusMatthew M Mirsky, Carley Mitchell, Augustine Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Bone Marrow Transplantation|September 18, 2020
History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
Leukemia & Lymphoma|January 19, 2021
Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemiaJiasheng Wang, Marcos de Lima, Brenda W Cooper, et al.
American Journal of Hematology|April 21, 2020
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction modelsGouri Dharmavaram, Shufen Cao, Suchitra Sundaram, et al.
Structure (London, England : 1993)|December 25, 2018
A Metastable Contact and Structural Disorder in the Estrogen Receptor Transactivation DomainYi Peng, Shufen Cao, Janna Kiselar, et al.
Leukemia & Lymphoma|July 12, 2020
Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemiaNaveed Ali, Benjamin Tomlinson, Leland Metheny, et al.
Transplantation and Cellular Therapy|April 8, 2021
Physical Activity and Sleep Measures Using a Fitness Tracking Device during Hematopoietic Cell Transplantation: A Pilot StudyNajla El Jurdi, Nora Nock, Pingfu Fu, et al.
Pageof 3